“…The high tolerance of LAMP to enzyme inhibitors allows for onsite assessment of clinical and biological samples without sample enrichment (Das et al., 2022 ). LAMP assays have been successfully used to detect the pathogens of many infectious diseases, including SARS‐CoV‐2 (Nuchnoi et al., 2023 ; Ooi et al., 2022 ), porcine epidemic diarrhoea virus and porcine circovirus type 2 (Areekit et al., 2022 ), West Nile virus (Tomar et al., 2022 ), herpesvirus of turkeys (Mescolini et al., 2022 ), Treponema pallidum (Becherer et al., 2020 ), Haemophilus ducreyi (Becherer et al., 2020 ), Ascaridia galli (Panich et al., 2023 ), Toxoplasma gondii (Xue et al., 2021 ), Ebola virus (Bonney et al., 2020 ) and Helicobacter pylori (Horiuchi et al., 2019 ; Panich et al., 2023 ). However, LAMP may result in non‐specific binding owing to the formation of primer dimers (Garg et al., 2022 ).…”